15600 Mulholland Drive
Bel Air, 90077
Health Panel: What's Jewish About Breast and Ovarian Cancer?
1 in 40 Ashkenazi Jews – men and women – carries a BRCA gene mutation, nearly 10 times the rate of the general population, making Jewish families significantly more susceptible to hereditary breast cancer and ovarian cancer. Recent studies show that Sephardic Jews may also be genetically predisposed to hereditary breast and ovarian cancer. Join us to learn from this panel of health experts and to get the latest information on genetics and prevention.
Moderated by Jenna Fields, California Regional Director, Sharsheret and featuring Noam Z. Drazin, MD and Rachel Shapira, ScM, LCGC.
Jenna Fields, MA, MSW, California Regional Director, Sharsheret, is a graduate of the Zelikow School of Jewish Nonprofit Management at Hebrew Union College and the School of Social Work at the University of Southern California. Jenna oversees Sharsheret’s office in the Greater Los Angeles community, and all local programmatic efforts including outreach, education, partnership development and fundraising.
Noam Z. Drazin, MD., Cedars Sinai Medical Group, specializes in the treatment of a wide range of solid tumors, cancers of the blood and lymphatic system, and blood disorders that are not related to cancer. After earning his medical degree from Albert Einstein College of Medicine in New York City, he completed an internship and a residency at Cedars-Sinai Medical Center. He received his hematology/oncology fellowship training in the combined program of Cedars-Sinai and Olive View/University of California, Los Angeles (UCLA) Medical Center. Dr. Drazin has special interests in education and communication, having completed intensive training in promoting effective communication with cancer patients and their families. He encourages patients to enroll in clinical trials as a way to receive the most advanced care, and he makes community presentations on the latest therapies and research in cancer care.
Rachel Shapira, ScM, LCGC, is a genetic counselor certified by the American Board or Genetic Counseling and licensed in California. She received her BA from Wesleyan University in 2000, with majors in Theater and Science in Society. She received her Master of Science degree from the Johns Hopkins School of Public Health/National Human Genome Research Institute Genetic Counseling Program in 2014. Prior to her genetic counseling career, Rachel worked in a myriad of roles and settings, from nonprofit to high tech. Before joining the UCLA team, she was a genetic counselor in the St. Joseph Hospital Cancer Genetics Program and at GeneTestNow, a non-profit initiative providing education about Jewish genetic diseases and carrier screening. In addition to her current clinical work, she volunteers with hereditary breast and ovarian cancer organizations including FORCE and Sharsheret. She enjoys presenting to patient and community groups, from high school seniors to rabbinical students, on the topics of hereditary cancer and Jewish genetic diseases.